Anti-Smoking Products Market - Global Outlook and Forecast 2022-2028

Anti-Smoking Products Market - Global Outlook and Forecast 2022-2028

  • Market Monitor Global
  • January 2022
  • Pharmaceutical
  • 66 pages

Report Description

The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).
This report contains market size and forecasts of Anti-Smoking Products in Global, including the following market information:
Global Anti-Smoking Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Smoking Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nicotine Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Smoking Products include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Smoking Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Smoking Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Smoking Products Market Segment Percentages, by Type, 2021 (%)
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Global Anti-Smoking Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Smoking Products Market Segment Percentages, by Application, 2021 (%)
Smokers aged 1824
Smokers aged 2544
Smokers aged 4564
Smokers aged 65 years or older
Global Anti-Smoking Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Smoking Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Smoking Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Smoking Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp

Have query on this report?

Make an Enquiry
1 Introduction to Research & Analysis Reports
1.1 Anti-Smoking Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
List of Tables
Table 1. Anti-Smoking Products Market Opportunities & Trends in Global Market
Table 2. Anti-Smoking Products Market Drivers in Global Market
Table 3. Anti-Smoking Products Market Restraints in Global Market
Table 4. Key Players of Anti-Smoking Products in Global Market
Table 5. Top Anti-Smoking Products Players in Global Market, Ranking by Revenue (2021)

Success Stories

Our Clients